Nicholas R. Leslie

Nick completed his first degree in Genetics at Cambridge University and a PhD at Glasgow University with David Sherratt, FRS. After PostDoctoral research at the Beatson Institute for Cancer Research, he moved to Dundee to work with Peter Downes and Philip Cohen at the inception of their pharmaceutical collaboration, the Division of Signal Transduction Therapy. It was in Dundee that Nick began studying the PI 3-kinase signalling pathway and PTEN. Nick was appointed as an Independent Investigator there in 2002 and moved his lab to Heriot Watt University in  2013. He was promoted to Professor in 2017, was Director of Research for the School of Engineering and Physical Sciences from 2019 until 2024 and was appointed as Associate Pricipal (Research Reputation) in 2026.